Bharat Biotech says awaiting CDSCO approval to launch Covaxin for children

Hyderabad, Oct 12: After getting approval from Subject Expert Committee (SEC) for Covaxin to be used for children in the 2 to 18 years age group with certain conditions, Bharat Biotech on Tuesday said they are awaiting further regulatory approvals from

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News